Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > What if Covid goes away or diminishes significantly?
View:
Post by Thylor09 on Dec 24, 2021 2:18pm

What if Covid goes away or diminishes significantly?

The company has several ways to deal with that


Most importantly is not a covid transport medium is a viral transport medium.


In 2019, pre covid, Canada did about 20 million in vtm 


Given MBX has a high quality made in Canada solution they should get a good piece buisiness even after covid diminishes

Also if covid is reduced expect a pick up in the antigen business as people have been reluctant to go in for tests during covid

That been said, neither vtm or the antigen business are the driver of this company going forward as they have 2 bigger opportunites
Comment by RazeKreations on Dec 24, 2021 2:30pm
In 2019 Canada imported 55 million dollars of vtm. That market has grown substantially since then and will continue to grow long after covid is under control. The Qap's market will continue to grow also. Cheaper to test and confirm those tests are accurate was a lesson learned this past two years. Microbix has a worldwide network of distributors that have been developed this past few years ...more  
Comment by Thylor09 on Dec 24, 2021 2:43pm
I dont believe they can access all of that yet, hence my 20 million number
Comment by prophetoffacts on Dec 24, 2021 3:01pm
This post has been removed in accordance with Community Policy
Comment by Thylor09 on Dec 24, 2021 3:11pm
Agree But quality assessment products for labs testing for infectious disease are even more important. As one big british lab found out to their detriment recently. Also this will be recurring revenue my favorite kind.
Comment by wizzdumb on Dec 24, 2021 3:19pm
Agree 100%, it's not going away and will be part of our lives forever. As Cameron says, we are entering the beginning of a "golden age of diagnostic testing" . Not just test capacity but test complexity via multiplex. When you go to the doc presenting symptoms you will be given a mltiplex test looking for a variety of possible culprits. This is the future and MBX is a leader and will ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities